KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Debt Ratio (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Debt Ratio for 16 consecutive years, with 0.41 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 8.79% year-over-year to 0.41, compared with a TTM value of 0.41 through Dec 2025, down 8.79%, and an annual FY2025 reading of 0.41, down 8.79% over the prior year.
  • Debt Ratio was 0.41 for Q4 2025 at Teva Pharmaceutical Industries, down from 0.42 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.51 in Q2 2021 and bottomed at 0.41 in Q4 2025.
  • Average Debt Ratio over 5 years is 0.47, with a median of 0.48 recorded in 2023.
  • The sharpest move saw Debt Ratio increased 8.07% in 2021, then dropped 8.79% in 2025.
  • Year by year, Debt Ratio stood at 0.48 in 2021, then dropped by 0.3% to 0.48 in 2022, then dropped by 5.36% to 0.46 in 2023, then dropped by 0.87% to 0.45 in 2024, then decreased by 8.79% to 0.41 in 2025.
  • Business Quant data shows Debt Ratio for TEVA at 0.41 in Q4 2025, 0.42 in Q3 2025, and 0.43 in Q2 2025.